Alan Talevi

19PUBLICATIONS
51CO-AUTHORS
Toxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Cheminformatics and quantitative structure-activity relationshipsProteins and peptidesFoetal development and medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|May 04, 2026
Lipid Nanoparticles with Stiripentol and Cannabidiol Oil: From Rational Optimization to Preclinical Characterization.

|Dec 31, 2025
Application of Data-Centric Supervised Machine Learning to Predict Phenotypic Activity Against Clinically Relevant Stages of Trypanosoma cruzi.

Nicolás Pérez-Mauad, Lucas N Alberca, Alejandra C Schoijet

|May 12, 2025
Discovery of Trypanosoma cruzi Carbonic Anhydrase Inhibitors by a Combination of Ligand- and Structure-Based Virtual Screening.

Denis N Prada Gori, Emilia M Barrionuevo, Lucas N Alberca

|Apr 17, 2025
Promising Prodiginins Biological Activities.

María F Ladetto, Melisa E Gantner, Boris E Rodenak-Kladniew

|Dec 22, 2023
Triclabendazole and clofazimine reduce replication and spermine uptake in vitro in Toxoplasma gondii.

Maria M Corvi, Franco Rossi, Agustina Ganuza

|Nov 02, 2023
A Combined Ligand- and Structure-Based Virtual Screening To Identify Novel NaV1.2 Blockers: In Vitro Patch Clamp Validation and In Vivo Anticonvulsant Activity.

Manuel A Llanos, Nicolás Enrique, Vega Esteban-López

Pageof 4

Frequent Collaborators

8 joint publications

Luciana Gavernet

5 joint publications

Manuel A Llanos

3 joint publications

Giuliana Muraca

3 joint publications

Catalina D Alba-Soto